News
CHMP gives positive opinion recommending authorisation to GSK’s CKD drug
Global biopharmaceutical company GSK has announced that EMA’s CHMP has given its drug treatment for symptomatic anaemia associated with chronic kidney disease (CKD) in adults on chronic maintenance dialysis a positive recommendation for authorisation.